throbber

`
`Ei + Fs ARMA GEA28a A) ISSN 0015-5667 Bema77S
`
`~ ‘AL 5/389
`
`ieee
`
`NAY mY garika HL Yta
`aphthnalaaloaqiga jag
`tin oof
`Japane
`Lialeagy
`
`
`
`1
`
`ALL 2004
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01131
`
`1
`
`ALL 2004
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01131
`
`

`

`The Effect on the Cornea of Various Vehicles
`for Cyclosporin Eye Drops
`
`Rodolfo M. Alba, Jr. Atsushi Kanai, Toshiyuki Takano,
`Chihiro Kobayashi and Akira Nakajima
`
`Department of Ophthalmology, Juntendo University, School of Medicine
`
`Kozo Kurihara
`
`Product Development Laboratories, Sankyo Co.
`
`Masaharu Fukami
`
`Biological Research Laboratories, Sankyo Co.
`
`Wetested several solvents, possible vehicles for Cyclosporin, (CYA) as to which
`had the least corneal toxicity. They were: peanut oil, palm oil, polyoxyethylene castor
`oil, medium chain-length triglyceride emulsion (MCT) and alpha cyclo-dextrin (a-
`CD). The concentration of CYA in each vehicle was: 1% in peanutoil, palm oil and
`MCT: 0.1% in polyoxyethylene castor oil and 0.08% in a-CD. The drugs and normal
`saline, which served as control, were instilled to rat corneasat frequencies of 10x (every
`30 min.) and 5x. Light microscopy revealed that in the MCT, @-CD and peanutoil
`groups, corneal thickness approximated that in the controls.
`In the next phase, done
`on rabbit corneas, weinstilled MCT (with and without CYA), a-CD and peanutoil 10x
`(every 30 min.). Normal saline wasapplied to the control eye. The Draizetest, ultra-
`sonic pachymetry,light and electron microscopic examination indicated that, compared
`to the other vehicles, a-CD exhibited significant corneal toxicity as evidenced by edema,
`diminution of microvilli on the epithelium and epithelial craters. Radioimmunoassay
`of CYAlevels in the cornea and aq. humorindicated that a-CD afforded the greatest
`CYA penetration of the cornea. We then tested 4 different concentrations of a-CD to
`determine the least toxic concentration. The concentrations were: 80, 40, 20 and
`10 mg./ml. of a-CD combined with 0.75, 0.25, 0.09 and 0.03 mg./ml. of CYA. They
`were applied to rabbit corneas 4x (every 2 hrs.). Histological and RIA studies indicate
`that 40.0 mg./ml a-CD with 0.25 mg./ml. CYA is an acceptable concentration.
`(Folia Ophthalmol. Jpn. 40: 902-908, 1989)
`
`a
`
`
`
`RBIS113 BRARABI-1-3 WR KPEPORAERS Sit
`Reprint requests to: Atsushi Kanai. M.D. Dept. of Ophthalmol., Juntendo Univ, School of Med.
`3-1-3 Hongo, Bunkyo-ku. Tokyo 113, Japan
`
`2
`
`

`

`Vol,
`
`40, No.
`
`a
`
`903
`
`I.
`
`Introduction
`
`[mmunosuppressive drugs have contri-
`buted greatly to the success of corneal trans-
`plantation.
`Ideally,
`they should be able
`to traverse the cronea in sufficient amounts
`
`to prevent rejection from taking place and
`the dose should be low enough to avoid
`occurrenceof toxic side-effects.
`Ciclosporin, a cyclic undecapeptide of
`fungal origin, has been discovered to be a
`useful immunosuppressive compoundandis
`used widely in organ transplantation.
`In
`previous studies,'~*’ it was
`shown that
`it
`can prolong survival of transplanted tissues
`by suppressing the function of T-lympho-
`cytes.
`It’s application in corneal
`trans-
`plantation has been rather limited due to
`it’s insolubility in water.
`The purpose of this studyis to investigate
`the effect on the cornea of various vehicles
`
`for Ciclosproin (CYA),
`
`Il. Materiais and Method
`
`We performed preliminary studies on
`rats by testing several solvents as possible
`vehicle for Ciclosporin.
`‘They were: Pea-
`nut oil, Palm oil, Polyoxyethylene castor
`oil, Medium Chain Length Triglyceride
`Emulsion (MCT) and Alpha cyclo-dextrin
`(a-CD). We applied normal saline on the
`control eye. MCT Emulsion consists of
`glycine,
`lecithin, ethylene oxidepropylene
`oxide and NaCl. The concentration of
`CYAin each eye drop was: 1% in Peanut
`oil, Palm and MCT; 0.1% in Polyoxyethy-
`lene castor oil and 0.08% in a-CD, These
`concentrations represented the maximum
`dose of CYA which the corneas did not
`opacity. The medications and normal sa-
`line were administered 10x (every 30 min.)
`and 5x a day. The rats were sacrificed
`with an overdose of anesthesia. After the
`corneas were harvested, they were examined
`under the light microscope and their thick-
`
`ness compared.
`Based on the results of the previous study,
`we did further experiments on rabbits. We
`tested 3 vehicles: MCT (with and without
`CYA), @-CD and Peanut oil. We omitted
`Polyoxyethylene castor oil and Palm oil.
`Normal saline was applied on the control
`eye. The drugs and normal saline were
`instilled 10x (every 30 min.). Ultrasonic
`pachymetry and the Draize test was per-
`formed before and after application of the
`eye drops. CYA concentration in the cor-
`nea and aq. humor was measured by ra-
`dioimmunoassay. Thirty minutes
`after
`the last eye drop,
`the rabbits were sacri-
`ficed with an overdose of anesthesia. After
`harvesting the corneas, one half was exa-
`mined under the light microscope and the
`other half with the electron microscope
`(both scanning and transmission).
`With the result of the study we tested +
`solutions of a-CD having different concen-
`trations following the previous procedure.
`The drugs were administered 4x (every 2
`hrs.), The
`corneas were examined by
`scanning
`electron microscopy. Corneal
`and aq. humor concentration of CYA was
`also determined by radioimmunoassay.
`
`Ill. Results
`
`Comparing the thickness of the rat cor-
`neas where the eye drops were admini-
`stered 10x and 5x showed that the conreas
`with MCT and Peaunt oil approximated
`the thickness of the control cornea (Fig.
`1,2). Edema was marked in the corneas
`where Palm oil and Polyoxyethylene cas-
`tor oil were administered.
`In the rabbit study ,Ultrasonic pachy-
`metry readings indicated that a-CD pro-
`duced the greatest amount of edema com-
`pared to the others (Table-1). This was
`(P<0.01).
`The
`statistically
`significant
`Draize test which is used to evaluate ocular
`lesions by assigning relative values to ocular
`
`3
`
`

`

` 0.08% CYA+ a-CD
`
`Fig.
`
`1
`
`Light micrograph of rat cornea after admi-
`nistrationof various vehicles with Ciclospo-
`rin. Frequency of administration was 10>
`(every 30 min.).
`
`0.1% CYA+Castor Oil
`
`
`
`Folia Ophthalmol. Jpn. 1989
`
`0.08%. CYA+«-CD}~
`
`~~
`
`0.1%. CYA+ Castor Oil
`
`Fig, 2. Light micrograph ofrat cornea after admi-
`nistration ofvarious vehicles with Ciclospo-
`rin. Frequencyof administration was5»
`
`Table 1 Pachymethry of rabbit cornea before and after administration of Ciclosporin
`with various vehicles
`Frequency : 10x (every 30 min.)
`
`drug
`
`;
`N
`
`before
`(mm)
`
`after
`(mm)
`
`difference a
`(mm)
`significance
`
`SN
`0,01—0,01
`0.334+0,01
`0.339+0.01
`3
`1% CYA+MCT
`p<0.01
`0.01-0,01
`0.366+0,05
`0,355+0,03
`3
`0.08% CYA+a-CD
`NS
`0.01 +0,03
`0.348+0,.03
`0,355+0.02
`3
`1% CYA+peanut oil
`
`
`
`
`8 0.358+0.02, 0.351=0,01(saline soln.)Control 0,01+0.01me
`NS : Not significant
`
`findings demonstrated that «-CD did not
`casue any irritation and no macroscopic
`change was noted.
`In contrast, minimal
`irritation was evident
`in the eyes where
`MCT(with and without CYA) was admin-
`istered.
`in the cor-
`We meausred the CYA level
`nea and aq. humor by means ofradioim-
`munoassay (Fig. 3).
`It revealed that
`the
`vehicle with the highest penetrating ability
`was a-CD andthe least was Peanut oil.
`The findings on gross examination was
`further elucidated with light microscopy.
`Whenwe compared the corneal thickness of
`
`the different samples. MCT approximated
`the thickness of the control cornea (Fig. 4).
`With the transmission electron microscope,
`the findings were unremarkable except for
`diminution in the numberof microvillae on
`the epithelium associated with a-CD (Fig.
`5.)
`This was corroborated by the find-
`ings of the scanning electron microscope
`(Fig. 6).
`It showed that compared to the
`others,
`the cornea with a-CD had more
`epithelial craters.
`In the last phase of our study wetested
`4 different concentrations of a-CD and
`they were 80, 40,20 and 10 mg./ml.
`com-
`
`4
`
`

`

`Vol.
`
`40, No. 5
`
`905
`
`bined with 0.75, 0.25, 0.09 and 0.03 mg./
`ml. of CYA respectively. Ultrasonic pach-
`ymetry indicated that the difference in the
`corneal
`thickness before and after appli-
`cation of the drugs were not statistically
`
`singificant. The Draize test revealed that
`80 and 40 mg./ml. of a-CD was minimally
`irritating, 20 mg./ml. was practically non-
`
`Frequency : 10x (Every 30 min.)
`Cornea
`i
`Ag. humor
`(n=3)
`(n=3)
`
`fg gr)
`
`1.0% CYA+Peanut Of==—*1.0% CYA-+MCT
`
`
`\
`
`HFACYA+
`Peanut
`il
`
`O.OBCYA ICYA
`+ C0 +MCT
`
`OO8.CYA MCYA Vcr +
`+00 +MCT
`Peanut
`oil
`Rabbits sacrificed 30min. after last eye drop.
`Fig. 3. Pachymetry of rabbit cornea before and
`after administration of various vehicles with
`Ciclosporin.
`
`inevarh
`5.000 0
`See4
`
`
`
`2
`Fig. 4
`
`;
`CYAlevel determination in the cornea and
`aq. humorafter administration of various
`vehicles with Ciclosporin.
`
`Control {Saline Sol'n.)
`
`
`
`Peanut Oil
`1.0" CYA+
`1.0% CYA+ MCT
`
`,
`he
`ea
`tage
`
`
`
`Fig. 5 Light micrograph of rabbit cornea after administration of various
`vehicles with Ciclosporin. Frequency of administration was 10
`(every 30 min.).
`
`5
`
`

`

`0.08% CYA+a-CD ee
`ag ee
`
`fe-£0 :80mg/me /
`CYA: 8.75mg/ml
`
`1989
`
`E -CO: JOmp/mi
`
`be
`
` Folia Ophthalmol. Jpn,
`CYA: 0.03mg/ml
`
`Fig. 6 TEMofrabbit cornea after administration
`of various vehicles with Ciclosporin. Fre-
`quency of administration was 10% (every
`30min.). Samples of 0.08% CYA+a-CD
`showed diminution in the number of micr-
`ovillae on the epithelium (arrow).
`
`‘irritating and 10 mg./ml. was completely
`non-irritating. Scanning electron micro-
`scopy demonstrated few epithelial erosions
`associated with 80 and 40 mg./ml. of a@-
`CD (Fig. 7).
`We measured the concentration of CYA
`in the cornea and aq, humor by radioim-
`munoassay. The sample associated with
`80 mg./ml. of a-CD had the highest
`level
`and the sample with 10 mg./ml. of a-GD
`the lowest (Fig. 8). Measuring the CYA
`level
`in the aq. humor gave unreliable
`values and were disregarded, We attri-
`buted this to inadequate procedure.
`
`IV. Discussion
`
`Despite the introduction of immunosup-
`pressives 30 years ago, graft rejection has
`remained a problem in corneal
`transplan-
`tation. The first generation immunosup-
`pressives
`indiscriminately blocked all cell
`
`Fig. 7
`
`SEMofrabbit cornea after administration
`of various vehicles with Ciclosporin. Fre-
`quency of administration-was 10* (every
`30 min.). Sample with 0.0896 CYA+a@-CD
`had moreepithelial craters (arrow) compa-
`red to the others.
`
`thereby negating it’s beneficial
`divisions
`effects. With the advent of newer drugs
`such as Ciclosporin, the success rate has in-
`creased. These new immunosuppressives
`are capable of selectively affecting certain
`subpopulation of immunocompetent cells
`thus
`preventing
`rejection
`from taking
`place.®
`The different routes of drug administra-
`tion have been previously discussed” and
`the topical routeis still the preferred means
`of instilling the drug in the anterior seg-
`ment of the eye. Aside from minimizing
`the occurrence of systemic reactions,®”it
`encourages patient compliance with the
`drug schedule, Previous studies attest to
`the efficacy of administrating Ciclosporin
`topically in preventing rejection from taking
`place."
`The objectives of our investigation are
`twofold. The first is to search for a suita-
`
`6
`
`

`

`Vol.
`
`40, No. 5
`
`Frequency: Every 2 hrs.
`
`(4x) (n=3)
`
`Cornea 1280+ 269
`
`0
`
`0.75 0.25 0.09 0.03 mg/me
`CYA
`aCD 80
`40
`20
`10 ng/me
`~ Rabbits sacrificed 30min. after last eye drop
`CYA concentration is maximum amount for
`solubility in «-CD
`
`Fig. 8
`
`SEM of rabbit cornea after administration
`of 4 different concentrations of a@-CD,
` Fr-
`equency of administration was 4% (every
`2 hrs.).
`
`ble vehicle which when combined with Ci-
`
`closporin would cause the least amount of
`corneal toxicity and the second is to deter-
`mine whether this new combination would
`
`be effective in suppressing the rejection
`phenomenon. This paper will address the
`first objective.
`A major obstacle in the application of
`Ciclosporin in ophthalmic preparations is
`it’s insolubility in water. Wetested several
`lipophilic vehicles on rat corneas in the
`initial phase of our study. These vehicles
`were: Medium Chain Length Triglyceride
`Emulsion
`(MCT), Alpha
`cyclo-dextrin
`(a-CD), Palm oil, Peaunt oil and Polyoxye-
`thylene castor oil.
`‘The test drugs were ap-
`plied at fixed intervals on one eye of rats
`while normal saline, which servedas control,
`was applied on the contralateral eye. After
`the corneas were harvested they were exa-
`mined histologically. The result of
`the
`examination indicated that there was signi-
`
`907
`
`ficant corneal edema associated with Polyo-
`xyethylene castor oil and Palm oil com-
`pared to the others. Thus,
`in the next
`phase of our study, we limited our
`test
`vehicles
`to three drugs and they were:
`MCT (with and without CYA), e-CD and
`Peanut oil. They were instilled on rabbit
`eyes at regular intervals while normal sa-
`line was applied to the control eye. Several
`procedures were also performed in conjun-
`ction with this phase, They were: ultra-
`sonic pachymetry, Draize test, histological
`examination under light and electron mi-
`croscopy and radioimmunoassay (RIA).
`The results showed that compared to the
`others a-GD caused a great amount ofcor-
`neal toxicity such as edema,
`loss of epithe-
`lial microvilli and epithelial erosion.
`‘The
`Draize test demonstrated that a-CD was
`notirritating unlike the others.
`We measured the CYA level in the cor-
`nea and aq. humor in order to assess the
`ability of the drug to traverse the cornea
`in substantial amounts.”~'’ The assay in-
`dicated that a-CD had the highest level of
`concentration and Peanut oil the least.
`
`With these facts in mind, we embarked
`on the third phase of our investigation and
`that was to determine the acceptable con-
`centration of @-CD that would give the
`Jeast
`amount of corneal
`toxicity. We
`evaluated 4 different
`concentrations of
`
`a-CD following the previous procedure and
`criteria, Evaluation ofthe results suggests
`that 20 mg./ml. of a-CGD+0.09 mg./ml. of
`CYA is the acceptable concentration.
`In
`addition,
`the value we obtained is within
`the maintainance level of CYA for
`renal
`transplant
`patients
`(500-1500 ng. /gr.).’”
`This study, being preliminary in nature,
`sought
`to investigate the effects of various
`vehicles with Ciclosporin on the cornea.
`It still remains to be resolved whether this
`new combination would be effective as a
`
`topical drug to suppress rejection of corneal
`grafts,
`
`7
`
`

`

`References
`
`Foets, B., Missotten, L., Vanderveeren, P. et.
`al.: Prolonged survival of allogenic corneal
`grafts in rabbits treated with topically applied
`Cyclosporin A: Systemic absorption and local
`immunosuppressive effects. Br. J. Ophthalmol.
`69: 600-613, 1985.
`Salisbury, J.D. & Gebhardt, B.: Suppression
`of corneal allograft
`rejection by Cyclosporin
`A. Arch. Ophthalmol. 99: 1640-1643, 1981.
`Mannis, M.J. & May, W.M.: Suppression
`of the corneal allograft reaction: An experi-
`mental comparison of Cyclosporin A and to-
`pical steroid. Cornea 2: 95-101, 1983.
`Serdaervic, O.N., Goichot-Bonnat, L., Foster,
`J.O. et al.: The effect of topical Cyclosporin
`A on corneal
`reepithelialization. Cornea 5:
`47-53, 1986.
`Hunter, P.A., Garner, A., Wilhelmus, K.R.
`et. al.: Corneal graft rejection: A new rabbit
`model and Cyclosporin A. Br. J. Ophthalmol.
`66: 292-302, 1982.
`Borel, J.F.: The mode of action of immuno-
`suppressive drugs. Jpn.
`J. Ophthalmol. 31:
`521-531, 1987.
`Behrens-Baumann, W., Theuring, 5., Frey, B.
`et al.: Ciclosporin concentration in the rabbit
`aqueous humor and cornea following subcon-
`junctival administration. Graefe’s Arch. Clin.
`Exp. Ophthalmol. 224: 368-370, 1986.
`Williams, K.A., Grutzmacher, R.D., Roussel.
`T.J. et al.: A comparison of the effects of top-
`ical Cyclosporin and topical steroid on rabbit
`cornealallograft rejection, Transplantation 39:
`242-244, 1985.
`Hoffmann, F., Wiederholt, M. & Késsendrup,
`
`3)
`
`4)
`
`8)
`
`9)
`
`Folia Ophthalmol. Jpn.
`
`1984
`
`D.: Der Einflug von Cyclosporin A, Dexame-
`thason und verschie denen Konservierungs-
`mitteln auf die epitheliale Wundheilung der
`denervierten Meerschwienchen
`hornhorst.
`Klin. Mbl. Augenheilk 189; 30-33, 1986.
`Kana, J.S., Hoffmann, F., Buchen, R.et. al.:
`Rabbit corneal allograft survival following top-
`ical administration of Cyclosporin A.
`Invest.
`Ophthalmol. Vis Sci 22: 686-690, 1982.
`Hoffmann, F. & Wiederholt, M.: Topical
`Cyclosporin A in the treatment of corneal graft
`reaction Cornea 5: 129, 1986.
`Behrens-Baumann, W., Theuring, 8. & Brewitt,
`H.: Theeffect of topical Cyclosporin A on the
`rabbit cornea -A clinical and electron micors-
`copic study. Graefe’s Arch. Clin. Exp. Oph-
`thalmol. 224: 520-524, 1986.
`Von Domarus, D., Béhnke, M., Meisner, M.
`et al.: Regeneration artefizieller Hornhautwan-
`den unter Cyclosporin A Augentropfen. Fortschr
`Ophthalmol. 83: 647-649, 1986.
`Hoffmann, F. & Wiederholt, M.: Lokale Be-
`handlung des Hornhauttransplantates
`beim
`Menschen mit Cyclosporin A. Klin. Mbl. Aug-
`enheilk 187; 92-96, 1985.
`Mosteller, M.W., Gebhardt, B.M., Hamilton,
`A. et al.: Penetration of topical Cyclosporin
`into the rabbit cornea, aqueous humor and
`serum. Arch. Ophthalmol. 103: 101-102, 1985.
`Bozkurt, F., Stierle, H. & Schollmeyer, P.: Single
`dose response kinetics of Cyclosporin, Clin,
`Nephrolog 28: 10-14, 1987.
`Wiederholt, M., Kossendrup. D., Schulz, W-
`et. al.: Pharmacokinetic of topical Cyclosporin
`A in the rabbit eye. Invest. Ophthalmol. Vis
`Sci 27: 519-523, 1986.
`
`10)
`
`11)
`
`12)
`
`13)
`
`14)
`
`16)
`
`17)
`
`8
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket